Eliminate the need for urine Bence Jones Protein testing
Studies indicate clearly that if you replace urine Bence Jones Protein tests with serum assays including the Freelite free light chains assay, during the initial investigation for Multiple Myeloma, all patients requiring medical intervention are identified.
"...the use of serum PEL plus FLC provides a simple and efficient initial diagnostic screen for high-tumor-burden monoclonal gammopathies such as MM, WM, and SMM. Urine studies and serum IFE can be ordered more selectively."1
"Urine tests are no longer necessary as part of the screening algorithm for identifying monoclonal gammopathies..."2
Remove the inconvenience and improve your detection rate
Increase your detection rate by including Freelite in your investigation protocol. Freelite in combination with SPE enables sensitive quantification of monoclonal gammopathies at diagnosis without the added complications and difficulties of urine collection and testing.1
The superior sensitivity of Freelite allows measurement down through the normal range allowing more accurate detection of Multiple Myeloma, Light Chain Multiple Myeloma, Nonsecretory Multiple Myeloma, AL amyloidosis and other B cell dyscrasias.3
Reduce the impact of patient compliance
Reports of only 40% patient compliance in producing 24-hour urines have been cited.4 Lack of compliance can be due to many factors including renal impairment, embarrassment and inconvenience. Now you can avoid these problems and obtain a sample every time as only a blood sample needs to be collected. Conveniently, you can collect this at the same time as blood is taken for other renal function tests.
Efficiency gains in the clinic:
Efficiency gains in the laboratory:
|
Initial Investigation Protocol
Evidence for the Investigation Protocol
Clinical Evidence for the Utility of Freelite
Serum Free Light Chain Information Pack
Click here to order your copy.

